The company develops a silicon chip automated architecture to deliver engineered therapies for genetic diseases including cancers at a massive scale, using a patient-safe, reliable and reusable manufacturing system. They enable healthcare providers to deliver a variety of different therapeutic molecules across different primary cell types, industrializing genome editing factories for cell & gene therapies and cell line development.